tiprankstipranks
SCYNEXIS Inc (DE:135A)
NASDAQ:135A
Germany Market
135A
SCYNEXIS
RESEARCH TOOLSreports

SCYNEXIS (135A) Stock News & Sentiment

Compare
1 Followers
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
Premium
Ratings
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
5d ago
SCYX
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
Premium
Company Announcements
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
3M ago
SCYX
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
Premium
Ratings
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
5M ago
SCYX
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
Premium
Company Announcements
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
5M ago
SCYX
SCYX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SCYX Upcoming Earnings Report: What to Expect?
5M ago
SCYX
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
Premium
Ratings
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
5M ago
SCYX
SCYNEXIS and GSK Amend License Agreement
Premium
Company Announcements
SCYNEXIS and GSK Amend License Agreement
5M ago
8K
SCYX
More DE:135A News >

135A News on the Web

Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
TipRanks News
Bullish
SCYNEXIS (SCYX) Gets a Buy from Guggenheim
TipRanks News
Bullish
SCYNEXIS Posts Narrower FY25 Loss, Advances Next-Gen Antifungal Pipeline
rttnews
Bullish
SCYNEXIS (SCYX) Initiates Phase 1 Trial for New Antifungal Therapy
GuruFocus News
Bullish
Scynexis announces first patients dosed in Phase 1 SAD, MAD trial of SCY-247
TipRanks News
Bullish
Cero Therapeutics appoints Eric Francois to board of directors
TipRanks News
Neutral
Scynexis announces presentation highlighting data from SCY-247
TipRanks News
Bullish
Scynexis (SCYX) Gains FDA Designations for Antifungal Therapy SCY-247
GuruFocus News
Bullish

News Score - Last 7 Days

Neutral
DE:135A
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:135A’s Media Buzz Sentiment?
1 articles about DE:135A were published this week. In an average week, 1.25 articles are published.
    What is DE:135A’s weekly average amount of articles?
    In an average week, 1.25 articles about DE:135A are published.
      What is DE:135A’s News Sentiment?
      100% of articles about DE:135A were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        INNMFAmplia Therapeutics
        HYPRHyperfine
        OVIDOvid Therapeutics
        ALMSAlumis Inc.
        NWPHFNewron Pharmaceuticals SpA
        Showing the stocks with the most bullish news sentiment over the past week